Holdbrook Mark J.
SEC CIK 1827564 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | VP, Clinical Affairs | 3,389 | — | $7,505 | 3 | 2023-03-15 | 2023-03-17 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.18M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Holdbrook Mark J. made no open-market trades at TARS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-21 | 2023-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Holdbrook Mark J. | VP, Clinical Affairs | S - Sale | $12.94 | -386 | 3,389 | -10% | -$4,993 |
| D | 2023-03-17 | 2023-03-16 | TARS | Tarsus Pharmaceuticals, Inc. | Holdbrook Mark J. | VP, Clinical Affairs | S - Sale+OE | $13.43 | -187 | 3,577 | -5% | -$2,511 |
| D | 2023-03-17 | 2023-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Holdbrook Mark J. | VP, Clinical Affairs | M - OptEx | — | +2,653 | 3,764 | +239% | — |
Purchase Sale Sale after option exercise All abbreviations